Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision
NCT ID: NCT04992741
Last Updated: 2021-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2020-09-01
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women
NCT07097766
The Effect of Motivational Interviewing on HPV-DNA Testing
NCT06662136
Impact of Education Methods on HPV Knowledge and Screening Behavior
NCT07017387
The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors
NCT04113902
Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination
NCT05175482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The control group will be subjected to routine processing without any intervention. Questionnaire forms were applied to the control group simultaneously with the experimental group. At the end of the study, a single-session motivational interview will be held by the researcher, since the patients in the control group have equal ethical rights. The primary result expected from the study is that mothers' perceptions of the benefit, sensitivity and severity of HPV vaccine increase, and their perception of barriers decreases. The secondary result expected from the study is the increase in mothers' knowledge about HPV infection and vaccination. The tertiary expected outcome of the study is that the mother sees her daughter at risk of HPV infection and decides to have her daughter vaccinated against HPV.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Health Belief Model Based Motivational Interview Group The application will be made by the researcher who has been trained in motivational interviewing techniques. Motivational interviews based on Health Belief Model will be made by telephone to mothers who have daughters studying in high school. There will be 3 interviews with mothers based on the benefits, barriers, sensitivity and severity perception structures of the Health Belief Model regarding HPV infection and vaccination, and each interview will last 15-20 minutes. One week after each interview, the questionnaire/scale forms will be sent via whatsapp and applied.
education and motivational interview
The control group will remain subject to the routine process without any intervention.
other
The control group will remain subject to the routine process without any intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
education and motivational interview
The control group will remain subject to the routine process without any intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Daughter not vaccinated against HPV,
3. Undecided about getting her daughter vaccinated against HPV,
4. Who doesn't plan to have their daughter vaccinated against HPV,
5. who agreed to participate in the research,
6. Literate,
7. Can speak Turkish,,
8. Having no hearing or sight impairment that will prevent communication,,
9. Able to talk on the phone and use whatsapp,,
10. Participants without a diagnosed psychiatric problem were included in the study..
Exclusion Criteria
2. Thinking of getting her daughter vaccinated against HPV,
3. Who refused to participate in the research,
4. Illiterate,
5. Don't speak Turkish,
6. People with hearing or sight impairments that may interfere with communication,
7. Can't talk on the phone and can't use whatsapp,
8. Participants with diagnosed psychiatric problems were excluded from the study.
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yasemin ATEŞEYAN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasemin ATEŞEYAN
lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasemin Ateşeyan
Role: STUDY_CHAIR
Turkey, Mersin University, Mersin, Yenişehir, Turkey, 33343
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mersin University
Mersin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ateseyan Y, Gungormus Z. Web and theory-based motivational interviews in encouraging mothers for HPV vaccination of their daughters: A randomized controlled study. J Pediatr Nurs. 2024 Sep-Oct;78:e279-e288. doi: 10.1016/j.pedn.2024.07.016. Epub 2024 Jul 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YASEMIN-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.